Filter
76
Filtered Results: 76
Text search:
Kunz,
M.
Featured
Recommendations
16
New Publications
16
Language
Document type
Guidelines
33
No document type
30
Studies & Reports
9
Manuals
2
Fact sheets
2
Countries / Regions
Russia
4
Global
3
Peru
2
Brazil
2
Colombia
1
Kenya
1
Ghana
1
Syria
1
Philippines
1
Mozambique
1
Africa
1
Guinea-Bissau
1
Latin America and the Carribbean
1
Germany
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
North America
1
Argentina
1
Eastern Europe
1
Sudan
1
Yemen
1
Angola
1
Authors & Publishers
Publication Years
Category
Gynaecology & Obstetrics
9
COVID-19
8
Guidelines
6
Maternal Health
6
Reproductive Health
4
Hepatitis
3
Studies & Reports
3
Paediatrics
2
Diabetes
2
Pediatrics
2
Chagas
2
TB
2
Communicable Diseases
1
Digital Health
1
Under-5 nutrition
1
Child Health
1
Disaster Preparedness
1
Community Health
1
Infection Control & Prevention (IPC)
1
NCD
1
Cardiovascular Diseases
1
Clinical Guidelines
1
WASH
1
Respiratory Infections
1
Immunization
1
Quality Control & Assurance
1
Surgery & Anaesthesia
1
General Guidelines
1
Needs Assessment
1
Primary Health Care
1
HIV & STI
1
Toolboxes
Clinical Guidelines
11
Detection & Diagnosis
5
Country specific documents
3
Midwives
3
HIV testing & services
2
Adults
2
Children & Adolescents
2
Treatment Guidelines HIV
2
Treatment Guidelines
2
Diagnostics & Laboratory Guidance
2
Clinical Aspects & Diagnostics
2
Women
2
TB
2
Volunteers
2
Behaviour Change/Life Skill Education
1
IPC
1
Treatment & Prevention
1
Preparedness, Response & Risk Communication
1
Key Resources
1
Influenza
1
Children
1
Hepatitis
1
Social Worker
1
Others
1
Physiotherapy & Rehabilitation
1
Discrimination & Stigma
1
Training
1
Infection Control General
1
Surveillance & Contact tracing
1
Essential Medicines & Medical Devices
1
Hygiene
1
Studies & Reports
1
Nuclear & Chemical Hazards
1
Capacity Building & Resources
1
Studies & Reports
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Drug resistant TB
1
Cerebral Palsy
1
Mental Health
1
Prevention of mother-to-child transmission (PMTCT)
1
HIV and coinfection
1
Antiretroviral Treatment ART
1
Refugees & Migrants
1
HIV in Key Populations
1
Social Determinants of Health
1
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were prepared following the WHO handbook for guideline dev...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu...
Update, 23 de junio de 2022
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu...
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health-care guidelines and protocols and health workers involved in the provision of care to women and their newborns during pregnancy, labour and childbirth; this inclu...
Therapeutics for Ebola virus disease
recommended
The WHO Ebola Virus Disease (EVD) Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with EVD. Providing guidance that is comprehensive and holistic for the optimal care of patients with EVD throughout their il...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Traitements contre la maladie à virus Ebola
recommended
Cette première version des orientations evolutives relatives a la prise en charge clinique de la MVE contient quatre nouvelles recommandations concernant l’utilisation de traitements contre la MVE, y compris deux recommandations fortes en faveur de l’utilisation de thérapies à base d’antico...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts...
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
19 February 2021
The overall objective of this prospective meta-analyses (PMA) is to estimate the effect of anti-IL-6 therapy compared with usual care in hospitalized patients with suspected or confirmed COVID-19. The primary comparison is of the class effect of anti-IL-6 therapies. It will also es...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
The COVID-19 pandemic has affected job satisfaction among healthcare workers; yet this has not been empirically examined in sub-Saharan Africa (SSA). We addressed this gap by examining job satisfaction and associated factors among healthcare workers in Ghana and Kenya during the COVID-19 pandemic. W...
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
